版本:
中国

Johnson & Johnson (JNJ.N)

JNJ.N ( 纽约证券交易所 )

132.02USD
23 Feb 2018
涨跌 (%)

$2.11 (+1.62%)
收盘
$129.91
开盘
$130.08
当日最高
$132.08
当日最低
$130.04
成交量
1,641,212
平均成交量
2,194,484
52 周最高
$148.32
52 周最低
$119.49

Chart for

概况

强生公司是一家主要从事保健领域产品的研发、制造及销售业务的控股公司。该公司通过消费品部门、医药部门及医疗器械部门运营。消费品部门提供用于婴儿护理、口腔护理、肌肤护理、成药市场、女性健康及伤口护理的产品。医药部门专注于开发免疫学、传染病、神经学、肿瘤学以及心血管及代谢疾病等医疗领域用药。医疗器械部门提供用于骨科治疗、外科... (更多)

概况

Beta: 0.75
市值(百万): $354,674.41
已发行股本(百万): 2,686.52
股息: 0.84
股息收益率 (%): 2.55

财务指标

  Industry Sector
P/E (TTM): -- 30.96 16.59
EPS (TTM): -- -- --
ROI: -- 14.08 35.07
ROE: -- 15.71 17.79

BRIEF-Johnson & Johnson Medical Devices Companies Acquire Orthotaxy

* JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES ACQUIRE ORTHOTAXY TO DEVELOP NEXT-GENERATION ROBOTIC-ASSISTED SURGERY PLATFORM IN ORTHOPAEDICS‍​ 全文
02/20 21:28

US STOCKS-S&P 500 caps off strongest week in five years

* Indexes end: Dow +0.08 pct, S&P 500 +0.04 pct, Nasdaq -0.23 pct 全文
02/17 06:31

美国股市:标普500指数连升六日,创五年最强周度表现

路透2月16日 - 美国股市标普500指数周五微幅收高,录得2013年来最快攀升的一周,尽管收盘回吐了盘中多数升幅,因之前一美国大陪审团指控多位俄罗斯人干预2016年美国总统大选。 全文
02/17 05:55

US STOCKS-S&P 500 caps off strongest week in five years

* Indexes end: Dow +0.08 pct, S&P 500 +0.04 pct, Nasdaq -0.23 pct 全文
02/17 05:35

US STOCKS-Wall Street erases gain after U.S. indicts Russians

* Indexes: Dow +0.19 pct, S&P 500 +0.16 pct, Nasdaq -0.09 pct 全文
02/17 04:01

US STOCKS-Wall St on course for sixth day of gains

* Healthcare stocks lead gainers on S&P, Dow (Changes comment, adds details, updates prices) 全文
02/17 01:08

UPDATE 2-FDA approves J&J prostate cancer treatment

Feb 14 The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy. 全文
02/15 06:46

BRIEF-FDA Approves Janssen Pharmaceutical's Erleada For A Certain Type Of Prostate Cancer

* SAYS APPROVED JANSSEN PHARMACEUTICAL'S ERLEADA FOR A CERTAIN TYPE OF PROSTATE CANCER USING NOVEL CLINICAL TRIAL ENDPOINT‍​ Source text for Eikon: Further company coverage: 全文
02/15 04:49

FDA approves J&J prostate cancer treatment

Feb 14 The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada treatment for use with prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy. 全文
02/15 02:47

UPDATE 2-Norway wealth fund CEO to firms: allow independent directors on your boards

* Graphic: http://tmsnrt.rs/2tskfub (Recasts with CEO interview) 全文
02/14 00:15

收益 vs. 预测